Saffron: A natural product with potential pharmaceutical applications

Journal of Pharmacy and Pharmacology

Volumn 67, Issue 12, 2015, Pages 1634-1649

  Christodoulou, Eirini ^a   Kadoglou, Nikolaos Pe ^b,c   Kostomitsopoulos, Nikolaos ^b   Valsami, Georgia ^a  

^a UNIVERSITY OF ATHENS   (Greece)

^b BIOMEDICAL RESEARCH FOUNDATION   (Greece)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

biological pharmacological evaluation; crocin; drugs from natural sources; natural products; saffron; safranal

Indexed keywords

CROCIN; GLUCOSE; LIPID; MORPHINE; PLANT MEDICINAL PRODUCT; SAFFRON; SAFRANAL; UNCLASSIFIED DRUG; PLANT EXTRACT;

ALZHEIMER DISEASE; ANTIATHEROSCLEROTIC ACTIVITY; ANTIDEPRESSANT ACTIVITY; ANTIDIABETIC ACTIVITY; ANTIINFLAMMATORY ACTIVITY; ANTINEOPLASTIC ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; ATHEROSCLEROSIS; CHEMOPROPHYLAXIS; COGNITION; CROCUS SATIVUS; DEPRESSION; DIABETES MELLITUS; DRUG ACTIVITY; DRUG EFFICACY; DRUG MECHANISM; DRUG POTENCY; DRUG SAFETY; DRUG STRUCTURE; GLUCOSE BLOOD LEVEL; HEART MUSCLE ISCHEMIA; HUMAN; IMMUNOMODULATION; LD50; LEARNING; LIPID BLOOD LEVEL; LIVER TOXICITY; LUNG TOXICITY; MENTAL DISEASE; NONHUMAN; NORMOCHROMIC NORMOCYTIC ANEMIA; OUTCOME ASSESSMENT; PARKINSON DISEASE; PHYTOCHEMISTRY; PISTIL STIGMA; SPATIAL MEMORY; TOXICITY TESTING; TRADITIONAL MEDICINE; TRANQUILIZING ACTIVITY; WITHDRAWAL SYNDROME; ANIMAL; CHEMISTRY; CROCUS; FLOWER; ISOLATION AND PURIFICATION; MEDICINAL PLANT; PHYTOTHERAPY;

ANIMALS; CROCUS; FLOWERS; HUMANS; PHYTOTHERAPY; PLANT EXTRACTS; PLANTS, MEDICINAL;

EID: 84955204896     PISSN: 00223573     EISSN: 20427158     Source Type: Journal    
DOI: 10.1111/jphp.12456     Document Type: Article

References (121)

1. Negbi M, ed. Saffron: Crocus sativus L. (Medicinal and Aromatic Plants-Industrial Profiles). Amsterdam, The Netherlands: Harwood Academic Publishers, 1999.
2. Bathaie SZ, Mousavi SZ,. New applications and mechanisms of action of saffron and its important ingredients. Crit Rev Food Scu Nutr 2010; 50: 761-786.
3. Schmidt M, et al. Saffron in phytotherapy: pharmacology and clinical uses. Wien Med Wochenschr 2007; 157: 315-319.
4. Hagh Nazari S, Keifi N, (2006) Saffron and various fraud matter in its production and trade. 2nd International Symposium on Saffron Biology and Technology.
5. Betti G, Schmidt M, (2006) Valorization of saffron (Crocus sativus). 2nd Int Symposium on Saffron Biology and Technology.
6. Kamalipour M, et al. Cardiovascular effects of saffron: an evidence-based review. Teh Univ Heart Ctr 2011; 6: 59-61.
7. Deng Y, et al. Studies on the pharmacological effects of saffron (Crocus sativus L.)-A review. Zhonguo Zhongn Yao Za Zhi 2002; 27: 565-568.
8. Giaccio M,. Crocetin from saffron: an active component of an ancient spice. Crit Rev Food Sci Nutr 2004; 44: 155-172.
9. Soeda S, et al. Pharmacological activities of crocin in saffron. J Nat Med 2007; 61: 102-111.
10. Kumar V, et al. Pharmacological profile of Crocus sativus-A comprehensive review. Pharmacologyonline 2011; 3: 789-811.
11. Moshiri M, et al. Clinical applications of saffron (Crocus sativus) and its constituents: a review. Drug Res 2014; 64: 1-9.
12. Bolhassani A, et al. Saffron and natural carotenoids: biochemical activities and anti-tumor effects. Biochim Biophys Acta 2014; 1845: 20-30.
13. Bhandari P,. Crocus sativus L. (saffron) for cancer chemoprevention: a mini review. J Trad ComplementMed 2015; 5: 81-87.
14. Pitsikas N,. The effect of Crocus sativus L. and its constituents on memory: basic studies and clinical applications. Evid Based Complement Alternat Med 2015; 2015: 1-7. http://dx.doi.org/10.1155/2015/926284.
15. Garcia-Olmo DC, et al. Effects of long-term treatment of colon adenocarcinoma with crocin, a carotenoid from saffron (Crocus sativus L.): an experimental study in the rats. Nutr Cancer 1999; 35: 120-126.
16. Feizzadeh B, et al. Cytotoxic effect of saffron stigma aqueous extract on human transitional cell carcinoma and mouse fibroblast. Urol J 2008; 5: 161-167.
17. Goyal S, et al. Preventive effect of crocin of Crocus sativus on hemodynamic, biochemical, histopathological and ultrastuctural alterations in isoproterenol-induced cardiotoxicity in rats. Phytomedicine 2010; 17: 227-232.
18. Joukar S, et al. The effect of saffron consumption on biochemical and histopathological heart indices of rats with myocardial infarction. Cardiovasc Toxicol 2010; 10: 66-71.
19. Georgiadou G, et al. Effects of the active constituents of Crocus sativus L., crocins, in an animal modelof obsessive-compulsive disorder. Neurosci Lett 2012; 528: 27-30.
20. Bathaie SZ, et al. Anticancer effects of crocetin in both human adenocarcinoma gastric cancer cells and rat model of gastric cancer. Biochem Cell Biol 2013; 91: 397-403.
21. Sun Y, et al. Crocin inhibits antitumor effects on human leukemia HL-60 cells in vitro and in vivo. Evid Based Complement Alternat Med 2013; 2013: 1-7.
22. Sadeghnia HR, et al. Effect of safranal, a constituent of saffron (Crocus sativus L.) on lipid peroxidation level during renal ischemia-reperfusion injury in rats. Iran J Basic Med Sci Fall 2005; 8: 179-185.
23. Koulakiotis NS, (2009) Development of a liquid chromatography methodology for the quantification of bioactive components of Crocus sativus and other endemic taxa. MSc Thesis. University of Patra-Greece: s.n.
24. Dezani S,., Donath A, ed. Trattato di Farmacognosia. Genua: 1895.
25. Pasquali G,. Dizionario del Commercio dei Signori Fratelli Savary. Venezia: Zafferano, 1770.
26. Abdullaev FI, Espinosa-Aquirre JJ,. Biomedical properties of saffron and its potential uses in cancer therapy and chemoprevention trials. Cancer Detect Prev 2004; 28: 426-432.
27. Premkumar K, et al. Protective effect of saffron (Crocus sativus L.) aqueous extract against genetic damage induced by anti-tumor agents in mice. Hum Exp Toxicol 2006; 25: 79-84.
28. Kianbakht S, Ghazavi A,. Immunomodulatory effects of saffron: a randomized double-blind placebo-controlled clinical trial. Phytother Res 2011; 25: 1801-1805.
29. Makhlouf H, et al. Determination of antioxidant activity of saffron taken from the flower of Crocus sativus grown in Lebanon. Afr J Biotechnol 2011; 10: 8093-8100.
30. Akhondzadeh S, et al. Crocus sativus L. in the treatment of mild to moderate depression: a double blind, randomized and placebo controlled trial. Phytother Res 2005; 19: 148-151.
31. Noorbala A, et al. Hydroalcoholic extract of Crocus sativus L versus fluoxetine in the treatment of mild to moderate depression: a double-blind, randomized pilot trial. J Ethnopharmacol 2005; 97: 281-284.
32. Agha-Hosseini M, et al. Crocus sativus L. (saffron) in the treatment of premenstrual syndrome: a double-blind, randomised and placebo controlled trial. BJOG 2008; 115: 515-519.
33. Akhondzadeh S, et al. A 22-week multicenter, randomized, double-blind controlled trial of Crocus sativus in the treatment of mild-to-moderate Alzheimer's disease. Psychopharmacology (Berl) 2010; 207: 637-643.
34. Bhat JV, Broker R,. Riboflavine and thiamine contents of saffron, Crocus sativus. Nature 1953; 172: 544-545.
35. Loukis A, et al. Constituents of Crocus sativus L. bulbs. Plant Med Phytother 1983; 17: 89-91.
36. Rios JL, et al. An update review of saffron and its active constituents. Phytother Res 1996; 10: 189-193.
37. Winterhalter P, Straubinger M,. Saffron-renewed interest in an ancient spice. Food Rev Int 2000; 16: 39-59.
38. Fernandez JA,. Biology, biotechnology and biomedicine of saffron. Recent Res Devel Plant Sc 2004; 2: 127-159.
39. Alonso GL, et al. Composition of crocins and picrocrocin from Spanish saffron (Crocus sativus L). J Food Qual 2001; 24: 219-233.
40. Buchecker R, Eugster CH,. Absolute configuration of picrocrocin. Helv Chi Acta 1973; 56: 1121-1124.
41. Curro P, et al. Valutazione della frazione volatile dello zafferano mediante gascromatografia dello spazio di testa. Rassegna Chimica 1986; 38: 331-334.
42. Kuhn R, Winterstein G,. Picrocrocin, the terpene glucoside of saffron and the biogenesis of the carotenoid-carboxylic acid. Naturwissenschaften 1933; 21: 527.
43. Dhingra VK, et al. Minor carotenoid glycosides from saffron (Crocus sativus). Indian J Chem 1975; 13: 339-341.
44. Speranza G, et al. 13-cis-crocin: a new crocinoid of saffron. Gazz Chim It 1984; 114: 189-192.
45. La Barre J, ed. Tractus digestif. Pharmacodinamic Biochimique, 12ve edn. Paris: Masson & C/ie, 1961.
46. Lequerc H,. Precis de Phytotherapie. Paris: Masson & C/ie, 1973.
47. Frank A,. Purpura resulting from artificial abortion. Deut Med Wochschr 1961; 86: 1618-1620.
48. Akhondzadeh S, et al. Comparison of Crocus sativus L. and imipramine in the treatment of mild to moderate depression: a pilot double-blind randomized trial. BMC Complement Altern Med 2004; 4: 12.
49. Akhondzadeh Basti A, et al. Comparison of petal of Crocus sativus L. and fluoxetine in the treatment of depressed outpatients: a pilot doubleblind randomized trial. Prog Neuropsychopharmacol Biol Psychiatry 2007; 31: 439-442.
50. Hosseinzadeh H, Jahanian Z,. Effect of Crocus sativus L. (saffron) stigma and its constituents, crocin and safranal, on morphine withdrawal syndrome in mice. Phytother Res 2010; 24: 726-730.
51. Imenshahidi M, et al. Effects of crocin on the acquisition and reinstatement of morphine-induced conditioned place preference in mice. Pharmacologyonline 2011; 1: 1007-1013.
52. Hosseinzadeh H, et al. Effects of saffron (Crocus sativus L.) and its active constituent, crocin, on recognition and spatial memory, after chronic cerebral hypoperfusion in rats. Phytother Res 2012; 26: 381-386.
53. Hosseinzadeh H, Noraei NB,. Anxiolytic and hypnotic effect of Crocus sativus aqueous extract and its constituents, crocin and safranal, in mice. Phytother Res 2009; 23: 768-774.
54. Akhondzadeh S, et al. Saffron in the treatment of patients with mild to moderate Alzheimer's disease: a 16-week, a randomized and placebo controlled trial. J Clin Pharm and Ther 2010; 35: 581-585.
55. Ahmad AS, et al. Neuroprotection by crocetin in a hemi-Parkinsonian rat model. Pharmacol Biochem Behav 2005; 81: 805-813.
56. Kianbakht S, Hajiaghaee R,. Anti-hyperglycemic effetcs of saffron and its active constituents, crocin and safranalm in alloxan-induced diabetic rats. J Med Plants 2011; 10: 82-89.
57. Shirali S, et al. Effect of crocin on the insulin resistance and lipid profile of streptozotocin-induced diabetic rats. Phytother Res 2013; 27: 1042-1047.
58. Kang C, et al. Saffron (Crocus sativus L.) increases glucose uptake and insulin sensitivity in muscle cells via multipathway mechanisms. Food Chem 2012; 135: 2350-2358.
59. He S, et al. Effect of crocin on experimental atherosclerosis in quails and its mechanisms. Life Sci 2005; 77: 907-921.
60. Bharti S, et al. Akt/GSK-3b/eNOS phosphorylation arbitrates safranal-induced myocardial protection against ischemia-reperfusion injury in rats. Eur J Nutr 2011; 51: 719-727.
61. Christodoulou E, et al. (2014) The impact of saffron administration on atherosclerosis development in an experimental animal model. AAPS Annual Meeting and Exposition, November 2-6, 2014, San Diego, USA.
62. Nair SC, et al. Antitumour activity of saffron (Crocus sativus). Cancer Lett 1991; 57: 109-114.
63. Bathaie SZ, et al. Saffron aqueous extract inhibits the chemically-induced gastric cancer progression in the Wistar albino rat. Iran J Basic Med Sci 2013b; 16: 27-38.
64. Khorasani G, et al. The effect of Saffron (Crocus sativus) extract for healing of second-degree burn wound in rats. Keio J Med 2008; 57: 190-195.
65. Hosseinzadeh H, et al. The effect of saffron, Crocus sativus stigma, extract and its constituents, safranal and crocin on sexual behaviors in normal male rats. Phytomedicine 2008; 15: 491-495.
66. Boroushaki MT, et al. Protective effect of safranal against hexachlorobutadiene-induced nephrotoxicity in rat. Iran J Med Sci 2007; 32: 173-176.
67. Halataei BS, et al. Saffron (Crocus sativus) aqueous extract and its constituent crocin reduces stress-induced anorexia in mice. Phytother Res 2011; 25: 1833-1838.
68. Karimi G, et al. Study of antidepressant effect of aqueous and ethanolic extracts of Crocus sativus in mice. Iranian Basic Med Sci 2001; 4: 11-15.
69. Hosseinzadeh H, et al. Antidepressant effect of Crocus sativus L. stigma extracts and their constituents, crocin and safranal, in mice. Acta Hort 2004; 650: 435-445.
70. Wang H, et al. Antidepressant properties of bioactive fractions from the extract of Crocus sativus L. J Nat Med 2010; 64: 24-30.
71. Pitsikas N, et al. Effects of the active constituents of Crocus sativus L., crocins, in an animal model of anxiety. Phytomedicine 2008; 15: 1135-1139.
72. Sugiura M, et al. Crocin (crocetin di-gentiobiose ester) prevents the inhibitory effect of ethanol on long-term potentiation in the dentate gyrus in-vivo. J Pharmacol Exper Ther 1994; 271: 703-707.
73. Sugiura M, et al. Ethanol extract of Crocus sativus L. antagonizes the inhibitory action of ethanol on hippocampal long-term potentiation in vivo. Phytother Res 1995; 9: 100-104.
74. Abe K, et al. Saffron extract prevents acetaldehyde-induced inhibition of long-term potentiation in the rat dentate gyrus in vivo. Brain Res 1999; 851: 287-289.
75. Abe K, Saito H,. Effects of saffron extract and its constituent crocin on learning behaviour and long-term potentiation. Phytother Res 2000; 14: 149-152.
76. Ebadi M,. Pharmacodynamic Basis of Herbal Medicine, 2nd edn. Boca Raton, FL, USA: CRC Press/Taylor and Francis Group, 2007: 525-527.
77. Papandreou MA, et al. Inhibitory activity on amyloid-β- aggregation and antioxidant properties of Crocus sativus stigmas extract and its crocin constituents. J Agric Food Chem 2006; 54: 8762-8768.
78. Bonnefort-Rousselot D,. Glucose and reactive oxygen species. Curr Opin Clin Nutr Metab Care 2002; 5: 561-568.
79. Rajaei Z, et al. Antihyperglycemic and antioxidant activity of crocin in streptozocin-induced diabetic rats. J Med Food 2013; 16: 1-5.
80. Assimopoulou AN, et al. Radical scavenging activity of Crocus sativus L. extract and its bioactive constituents. Phytother Res 2005; 19: 997-1000.
81. Kanakis CD, et al. An overview of structural features of DNA and RNA complexes with saffron compounds: models and antioxidant activity. J Phytochem Photobiol B 2009; 95: 204-212.
82. Kanakis CD, et al. DNA interaction with saffron's secondary metabolites safranal, crocetin, and dimethylcrocetin. DNA Cell Biol 2007a; 26: 63-70.
83. Kanakis CD, et al. Interaction of tRNA with safranal, crocetin and dimethylcrocetin. J Biomol Struct Dyn 2007b; 24: 537-546.
84. Pham TQ, et al. Antioxidant properties of crocin from Gardenia jasminoides Ellis and study of the reactions of crocin with linoleic acid and crocin with oxygen. J Agric Food Chem 2000; 48: 1455-1461.
85. Abduallev FI,. Biological effects of saffron. Biofactors 1993; 4: 83-86.
86. Mousavi S, et al. Protective effect of saffron extract and crocin on reactive oxygen species-mediated high glucose-induced toxicity in PC12 cels. Cell Mol Neurobiol 2010; 30: 185-191.
87. Ordoudi SA, et al. Further examination of antiradical properties of Crocus sativus stigmas extract rich in crocins. J Agric Food Chem 2009; 57: 3080-3086.
88. Min X, et al. Crocetin inhibits leukocyte adherence to vascular endothelial cells induced by AGEs. J Ethnopharmacol 2006; 107: 25-31.
89. Xu G, et al. Increased expression ratio of Bcl-2/bax is associated with crocin-mediated apoptosis in bovine aortic endothelial cells. Basic Clin Pharmacol Toxicol 2007; 100: 31-35.
90. Alavizadeh SH, Hosseinzadeh H,. Bioactivity assessment and toxicity of crocin: a comprehensive review. Food Chem Toxicol 2014; 64: 65-80.
91. Singla RK, Bhat GV,. Crocin: an overview. Indo Glob J Pharm Sci 2011; 1: 281-286.
92. Gainer JL, et al. The effect of crocetin on hemorrhagic shock in rats. Circ Shock 1993; 41: 1-7.
93. Fatehi Hassanabad Z, et al. Endothelial dysfunction in aortic rings and mesenteric beds isolated from deoxycorticosterone acetate hypertensive rats: possible involvement of protein kinase C. Eur J Pharmacol 2004; 494: 199-204.
94. Hosseinzadeh H, Sadeghnia HR,. Safranal, a constituent of Crocus sativus (saffron), attenuated cerebral ischemia induced oxidative damage in rat hippocampus. J Pharm Pharm Sci 2005; 8: 394-399.
95. Rezaee R, Hosseinzadeh H,. Safranal: From an aromatic natural product to a rewarding pharmacological agent. Iran J Basic Med Sci 2013; 16: 12-26.
96. Abdullaev FI, et al. Pattern of childhood cancer mortality in Mexico. Arch Med Res 2000; 31: 526-531.
97. Escribano J, et al. The cytotoxic effect of glucoconjugate extracted from corns of saffron plant (Crocus sativus) on human cell lines in culture. Planta Med 2000; 66: 157-162.
98. Geromichalos GD, et al. Safranal, a Crocus sativus constituent suppresses the growth of K-562 cells of chronic myelogenous leukemia. In silico and in vitro study. Food Chem Toxicol 2014; 74: 45-50.
99. Abdullaev FI,. Cancer chemopreventive and tumoricidal properties of saffron (Crocus sativus L. Exp Biol Med (Maywood) 2002; 227: 20-25.
100. Das I, et al. Saffron suppresses oxidative stress in DMBA-induced skin carcinoma: a histopathological study. Acta Histochem 2010; 112: 317-327.
101. Inoue E, et al. Pharmacological properties of N-095, a drug containing red ginseng, polygala root, saffron, antelope horn and aloe wood. Am J Chin Med 2005; 33: 49-60.
102. Bhargava BK,. Medicinal uses and pharmacological properties of Crocus sativus Linn (saffron). Int J Pharm Pharm Sci 2011; 3: 22-26.
103. Shoshtari ME, et al. Anti-tumor activity of safranal against neuroblastoma cells. Phcog Mag 2014; 10, Suppl S2: 419-424.
104. Bakshi H, et al. DNA fragmentation and cell cycle arrest: a hallmark of apoptosis induced by crocin from Kashmiri saffron in a human pancreatic cancer cell line. Asian Pac J Cancer Prev 2010; 11: 675-679.
105. Nair SC, et al. Saffron chemoprevention in biology and medicine: a review. Cancer Biother 1995; 10: 257-264.
106. Abduallev FI, Frenkel GD,. Saffron in biological and medical research. In:, Negbi M, ed. Saffron Crocus sativus L. Amsterdam, The Netherlands: Harwood Academic Publishers, 1999: 103-113.
107. Molnar J, et al. Membrane associated antitumor effects of crocine-ginseniside- and cannabinoid derivates. Anticancer Res 2000; 20 (2a): 861-867.
108. Smith TAD,. Carotenoids and cancer: prevention and potential therapy. Br J Biomed Sci 1998; 55: 268-275.
109. Bani S, et al. Selective Th2 upregulation by Crocus sativus: a neutraceutical spice. Hindawi Publishing Corporation. Evid Based Complement Alternat Med 2011; 2011: 1-9 (Article ID 639862).
110. Bayrami G, Boskabadi MH,. The potential effect of the extract of Crocus sativus and safranal on the toral and differential white blood cells of ovalbumine-sensitized guinea pigs. RPS 2012; 7: 249-255.
111. Modabbernia A, et al. Effect of saffron on fluoxetine-induced sexual impairment in men: randomized double-blind placebo-controlled trial. Psychopharmacology (Berl) 2012; 223: 381-388.
112. Kashani L, et al. Saffron for treatment of fluoxetine-induced sexual dysfunction in women: randomized double-blind placebo controlled study. Hum Psychopharmacol Clin Exp 2013; 28: 54-60.
113. Shamsa A, et al. Evaluation of Crocus sativus L. (saffron) on male erectile dysfunction: a pilot study. Phytomedicine 2009; 16: 690-693.
114. Safarinejad MR, et al. An open label, randomized, fixeddose, crossover study comparing efficacy and safety of sildenafil citrate and saffron (Crocus sativus) for treating erectile dysfunction in men naive to treatment. Int J Impot Res 2010; 22: 240-250.
115. Karimi G, et al. Evaluation of subacute toxicity of aqueous extract of Crocus sativus L. stigma and petal in rats. J Med Plants 2004; 3: 29-35.
116. El-Maraghy SA, et al. Hepatoprotective potential of crocin and curcumin against iron overload-induced biochemical alterations in rat. Afr J Biochem Res 2009; 3: 215-221.
117. Hosseinzadeh H, et al. Acute and sub-acute toxicity of crocin, a constituent of Crocus sativus L. (saffron), in mice and rats. Pharmacologyonline. 2010; 2: 934-951.
118. Hosseinzadeh H, et al. Acute and subacute toxicity of safranal, a constituent of saffron, in mice and rats. Iran J Pharm Res 2013; 12: 93-99.
119. Modaghegh MH, et al. Safety evaluation of saffron (Crocus sativus) tablets in healthy volunteers. Phytomedicine 2008; 15: 1032-1037.
120. Mohamadpour AH, et al. Safety evaluation of crocin (a constituent of saffron) tablets in healthy volunteers. Iran J Basic Med Sci 2013; 16: 39-46.
121. Madaus G,. Crocus. Echter Safran, Iridaceae. Lehrbuch der biologischen Heilmittel. Leipzig, Ravensburg: Mediamed Verlag, 1938.